Package Leaflet: Information for the User
Efedrina Aguettant 3 mg/ml, Solution for Injection in Pre-filled Syringes
Ephedrine Hydrochloride
(Hereafter referred to as “Ephedrine Injectable”)
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the Package Leaflet
This medicine is used for the management of low blood pressure induced by anesthesia.
Do not use Ephedrine Injectable:
Warnings and Precautions
Consult your doctor before using Ephedrine Injectable:
Using Ephedrine Injectable with Other Medicines
Tell your doctor if you are using, have recently used, or might use any other medicines.
This information is especially important with the following medicines:
Pregnancy and Breastfeeding
The use of ephedrine should be avoided during pregnancy and used with caution, only when necessary.
Depending on your condition, and following your doctor's recommendations, breastfeeding may be suspended for several days after administration of ephedrine.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor, pharmacist, or nurse for advice before using this medicine.
Interference with Diagnostic Tests
This medicine contains an active ingredient that may cause positive results in doping tests.
Ephedrine Injectable contains Sodium
This medicine contains 33.9 mg of sodium (a major component of table salt/kitchen salt) per 10 ml pre-filled syringe. This is equivalent to 1.7% of the maximum daily intake of sodium recommended by the WHO for an adult.
Your doctor or nurse will administer this medicine to you through a vein (intravenously).
Your doctor will decide what dose is appropriate and when the injection should be given.
The recommended dose is:
Adults and Elderly
You will be given a slow injection of 3 to 6 mg (maximum 9 mg) into a vein, repeated if necessary, every 3-4 minutes up to a maximum of 30 mg.
The total dose should not exceed 150 mg in a 24-hour period.
Use in Children and Adolescents
Ephedrine 3 mg/ml solution for injection in pre-filled syringe is not recommended for use in children under 12 years due to insufficient data on efficacy, safety, and dosage recommendations.
The dosage and method of administration are the same as for adults.
Patients with Kidney or Liver Disease
No dose adjustment is recommended for patients with kidney or liver disease.
For more information about the use of this medicine, consult your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most serious side effects that require immediate medical attention are:
The following are other side effects that you might experience.
Common(may affect up to 1 in 10 people):
Frequency Not Known(cannot be estimated from the available data):
Reporting of Side Effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the label of the syringe. Your doctor or nurse will check this.
Store the blister in the carton to protect it from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Ephedrine Injectable
Appearance of the Product and Pack Size
Ephedrine Injectable is a clear, colorless liquid. It is provided in a 10 ml polypropylene syringe with a polypropylene cap and a security seal, packaged individually in a transparent blister.
The pre-filled syringes are available in packs of 1, 5, 10, 12, and 20 syringes.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
LABORATOIRE AGUETTANT
1, rue Alexander Fleming
69007 LYON
France
Manufacturer:
LABORATOIRE AGUETTANT
1, rue Alexander Fleming
69007 LYON
France
or
LABORATOIRE AGUETTANT
Lieu-dit “Chantecaille”
07340 CHAMPAGNE
France
Local Representative:
AGUETTANT IBERICA
C/Pau claris, 139, Pral. 2
08009, Barcelona-Spain
Date of Last Revision of this Leaflet:December 2022.
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).